Jane Street
INDV icon

Jane Street’s Indivior Pharmaceuticals INDV Stock Holding History

Jane Street’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Buy
60,800
+27,000
+80% +$979K ﹤0.01% 4788
2026
Q1 		$1.03M Buy
33,800
+11,700
+53% +$386K ﹤0.01% 6438
2025
Q4 		$793K Buy
+22,100
New +$675K ﹤0.01% 6637

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's INDV Position: Q2 2026 in Review

Jane Street opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 5,983 shares worth $245K. The stake represents ﹤0.01% of the portfolio and ranks #9642 among its holdings. This is a return to the name: Jane Street previously reported a position in INDV as recently as Q3 2025.

Jane Street first reported a position in INDV in Q1 2024 and has held it in 7 quarters since. The position peaked at $16.4M in Q3 2025. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Jane Street held 5,983 shares of Indivior Pharmaceuticals worth $245K as of Q2 2026.
  • Indivior Pharmaceuticals was a new Jane Street position in Q2 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9642 holding.
  • Jane Street first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
  • Jane Street's Indivior Pharmaceuticals position peaked at $16.4M in Q3 2025.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.